Bone densitometry firm Lunar of Madison, WI, announced this month that it and Stanford University have filed suit against Norland and its parent, Norland Medical Systems, in the U.S. District Court for the Western District of Wisconsin. The suit claims
Bone densitometry firm Lunar of Madison, WI, announced this month that it and Stanford University have filed suit against Norland and its parent, Norland Medical Systems, in the U.S. District Court for the Western District of Wisconsin. The suit claims that White Plains, NY-based Norland is infringing on a patent held by Stanford and licensed to Lunar. Issued in 1987, the patent covers scanned x-ray selective imaging systems, according to Lunar executives.
Lunar has also filed suit against International Medical Research Ottawa (IMRO) of Montreal. The suit claims that IMRO has infringed on Lunars Canadian patent for ultrasound bone measurement technology with some of its products, including its ultrasound bone measurement scanner Paris. Norland distributes these products in countries outside Canada (SCAN 9/17/97).
Norland claimed that the suit filed by Lunar is without merit. The firm also said that IMROhas denied that its ultrasound product infringes Lunars Canadian patent.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.